Cell, tissue and gene products with marketing authorization in 2018 worldwide
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Cell and gene therapies (CGTs) are progressively entering into clinical practice in different parts of the world. The International Society for Cell & Gene Therapy (ISCT), a global scientific society, has been committed since 1992 to supporting and developing knowledge on clinical applications of CGTs. Considering the number of products that have been progressively approved and, in some cases, withdrawn in recent years, the ISCT would like to present a brief annual report on CGTs with marketing authorization (MA) in different regions. This article reflects the dynamic momentum around authorized CGTs coinciding with the parallel increase of unproven approaches where cells are delivered without appropriate and rigorous scientific and regulatory assessment and authorization. This is intended to be a living document with a yearly update linked to a dedicated section of the ISCT website for faster adjustments. The aim is to ultimately inform, by periodic snapshots, the scientific community, healthcare stakeholders and patient associations on authorized CGT products as a way to increase communication around the approved therapeutic approaches charged with heightened expectations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Balancing safety and innovation for cell-based regenerative medicine
Marks, P., & Gottlieb, S. (2018) · New England Journal of Medicine · doi:10.1056/nejmsr1715626 · Cited by 173
Cited by
Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review
Mastrolia, I., Foppiani, E. M., Murgia, A., Candini, O., Samarelli, A. V., Grisendi, G., Veronesi, E., Horwitz, E. M., & Dominici, M. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0044 · Cited by 350
Self-citationMesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Krampera, M., & Le Blanc, K. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.09.006 · Cited by 260
Biomimetic immunomodulation strategies for effective tissue repair and restoration
Villarreal-Leal, R. A., Healey, G. D., & Corradetti, B. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113913 · Cited by 86
Grau-Vorster, M., Laitinen, A., Nystedt, J., & Vives, J. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1279-9 · Cited by 61
Hurdles to uptake of mesenchymal stem cells and their progenitors in therapeutic products
Childs, P. G., Reid, S., Salmeron-Sanchez, M., & Dalby, M. J. (2020) · Biochemical Journal · doi:10.1042/bcj20190382 · Cited by 27
Metadata
- Authors
- Cuende, N., RASKO, J. E. J., KOH, M. B. C., DOMINICI, M., & IKONOMOU, L.
- Venue
- Cytotherapy
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 20
- Issue
- 11
- Pages
- 1401-1413
- ISSN
- 1465-3249 (ISSN-L)
- OpenAlex
- W2898588727
- Cited by
- 111
- References
- 1
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.